Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Lacutamab in Patients with Relapsed and/or Refractory Sézary Syndrome: Translational Analysis from the Tellomak Phase 2 Trial

Blood (2024) 144 (Supplement 1): 1609.

https://doi.org/10.1182/blood-2024-200587

Published: 2024

Journal Articles

Health-Related Quality of Life in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma Treated By Lacutamab: Patient-Reported Outcomes from the Phase 2 Tellomak Trial

Blood (2024) 144 (Supplement 1): 466.

https://doi.org/10.1182/blood-2024-194796

Published: 2024

Journal Articles

Lacutamab in Patients with Relapsed and Refractory Sèzary Syndrome: Results from the Tellomak Phase 2 Trial

Blood (2023) 142 (Supplement 1): 185.

https://doi.org/10.1182/blood-2023-173806

Published: 2023

Journal Articles

Lymphopenia Confers Poorer Prognosis in Myelodysplastic Neoplasms (MDS) with Very Low and Low IPSS-M

David Fandrei, Tony Huynh, Marie Sebert, Lorea Aguinaga, Valeria Bisio, Marion Espéli, Karl Balabanian, Hélène Moins-Teisserenc, Antoine Toubert, Nicolas Dulphy, Pierre Fenaux, Lionel Ades, Lin-Pierre Zhao

Blood (2023) 142 (Supplement 1): 4597.

https://doi.org/10.1182/blood-2023-187707

Published: 2023

Journal Articles

Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial

Martine Bagot, Youn H. Kim, Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Neha Mehta-Shah, Olivier Dereure, Marie Beylot-Barry, Stéphane Dalle, Eric D Jacobsen, Auris Huen, Andrea Combalia, Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Michael S. Khodadoust, Julien Viotti, Christine Paiva, Marianna Muller, Pierluigi Porcu

Blood (2022) 140 (Supplement 1): 3760–3761.

https://doi.org/10.1182/blood-2022-160239

Published: 2022

Journal Articles

Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients

Adèle de Masson, Delphine Darbord, Gabor Dobos, Marie Boisson, Marie Roelens, Caroline Ram-Wolff, Charles Cassius, Hélène Le Buanec, Pierre de la Grange, Fanélie Jouenne, Baptiste Louveau, Aurélie Sadoux, Jean-David Bouaziz, Anne Marie-Cardine, Martine Bagot, Hélène Moins-Teisserenc, Samia Mourah, Maxime Battistella

Blood (2022) 139 (12): 1820–1832.

https://doi.org/10.1182/blood.2021013341

Published: 2022

Journal Articles

Early Immune Reconstitution after Hematopoietic Stem Cell Transplantation for Adolescents and Adults with Sickle Cell Disease

Loïc Vasseur, Florence Morin, Corinne Pondarré, Florian Chevillon, Aude-Marie Fourmont, Regis Peffault De Latour, Nicolas Boissel, Hélène Moins-Teisserenc, Sophie Caillat-Zucman, Nathalie Dhedin

Blood (2021) 138 (Supplement 1): 3907.

https://doi.org/10.1182/blood-2021-147133

Published: 2021

Journal Articles

Patient Characteristics of Long-Term Responders to Mogamulizumab: Results from the MAVORIC Study

Youn H. Kim, MD, Michael S. Khodadoust, MD PhD, Adele de Masson, MD PhD, Hélène Moins-Teisserenc, Takahiro Ito, MSc, Karen Dwyer, BA, Fiona Herr, PhD, Martine Bagot, MD PhD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-141379

Published: 2020

Journal Articles

Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity

Marie Roelens, Marc Delord, Caroline Ram-Wolff, Anne Marie-Cardine, Antonio Alberdi, Guitta Maki, Laurence Homyrda, Armand Bensussan, Martine Bagot, Antoine Toubert, Hélène Moins-Teisserenc

Blood (2017) 130 (12): 1468–1471.

https://doi.org/10.1182/blood-2017-03-772996

Published: 2017

Includes: Supplemental data

Journal Articles

Newly-Generated Regulatory B- and T-Cells Are Associated with Clinical Improvement and Reversal of Dermal Fibrosis in Systemic Sclerosis Patients after Autologous Hematopoietic Stem Cell Transplantation

Lucas C M Arruda, João R Lima-Júnior, Emmanuel Clave, Daniela A Moraes, Corinne Douay, Isabelle Fournier, Hélène Moins-Teisserenc, Dimas Tadeu Covas, MD, PhD, Kelen Malmegrim, Dominique Farge, Leandra Ramalho, Antoine Toubert, Maria Carolina Oliveira

Blood (2016) 128 (22): 4625.

https://doi.org/10.1182/blood.V128.22.4625.4625

Published: 2016

Journal Articles

Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication

Salomé Glauzy, Juliette Soret, Isabelle Fournier, Corinne Douay, Hélène Moins-Teisserenc, Régis Peffault de Latour, Guitta Maki, Marie Robin, Gérard Socié, Antoine Toubert, Emmanuel Clave

Blood (2014) 124 (15): 2459–2462.

https://doi.org/10.1182/blood-2014-05-573303

Published: 2014

Includes: Supplemental data

Journal Articles

NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation

Philippe Haas, Pascale Loiseau, Ryad Tamouza, Jean-Michel Cayuela, Hélène Moins-Teisserenc, Marc Busson, Guylaine Henry, Christine S. Falk, Dominique Charron, Gérard Socié, Antoine Toubert, Nicolas Dulphy

Blood (2011) 117 (3): 1021–1029.

https://doi.org/10.1182/blood-2010-02-269381

Published: 2011

Includes: Supplemental data

Journal Articles

DNA vaccination with all- trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4 + and CD8 + T-cell activation in an acute promyelocytic leukemia mouse model

Kouichi Furugaki, Katerina Pokorna, Carole Le Pogam, Masayuki Aoki, Murielle Reboul, Véronique Bajzik, Patricia Krief, Anne Janin, Marie-Elena Noguera, Robert West, Dominique Charron, Christine Chomienne, Marika Pla, Hélène Moins-Teisserenc, Rose Ann Padua

Blood (2010) 115 (3): 653–656.

https://doi.org/10.1182/blood-2007-08-109009

Published: 2010

Includes: Supplemental data

Journal Articles

DNA Vaccination and All-Trans Retinoic Acid Treatment-Induced Long Term Survival Requires CD4+ and CD8+ T-Cell Activation in An APL Mouse Model.

Rose Ann Padua, PhD, Kouichi Furugaki, MD, PhD, Helene Moins-Teisserenc, MD, PhD, Katerina Pokorna, Carole Le Pogam, Murielle Reboul, Masayuki Aoki, PhD, Veronique Bajzik, Patricia Krief, PhD, Anne Janin, MD, PhD, Maria-Elena Noguera, MD, Robert West, PhD, Marie-Helene Schlageter, PhD, Dominique Charron, MD, PhD, Marika Pla, PhD, Christine Chomienne, MD, PhD

Blood (2008) 112 (11): 962.

https://doi.org/10.1182/blood.V112.11.962.962

Published: 2008

NARROW

Lacutamab in Patients with Relapsed and/or Refractory Sézary Syndrome: Translational Analysis from the Tellomak Phase 2 Trial

Health-Related Quality of Life in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma Treated By Lacutamab: Patient-Reported Outcomes from the Phase 2 Tellomak Trial

Lacutamab in Patients with Relapsed and Refractory Sèzary Syndrome: Results from the Tellomak Phase 2 Trial

Lymphopenia Confers Poorer Prognosis in Myelodysplastic Neoplasms (MDS) with Very Low and Low IPSS-M

Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial

Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients

Early Immune Reconstitution after Hematopoietic Stem Cell Transplantation for Adolescents and Adults with Sickle Cell Disease

Patient Characteristics of Long-Term Responders to Mogamulizumab: Results from the MAVORIC Study

Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity

Newly-Generated Regulatory B- and T-Cells Are Associated with Clinical Improvement and Reversal of Dermal Fibrosis in Systemic Sclerosis Patients after Autologous Hematopoietic Stem Cell Transplantation

Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication

NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation

DNA vaccination with all- trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4 + and CD8 + T-cell activation in an acute promyelocytic leukemia mouse model

DNA Vaccination and All-Trans Retinoic Acid Treatment-Induced Long Term Survival Requires CD4+ and CD8+ T-Cell Activation in An APL Mouse Model.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only